Clinical-supply enquiries
Clinical-supply enquiries to GALVANTA COMPANY LIMITED concern proposed investigational-medicine arrangements; identify the sponsor, study, jurisdiction and authorised scope.
Study-material planning
Identify the sponsor, proposed countries, study reference and the material concerned.
Batch responsibilities
State the proposed manufacturing, packaging and release responsibilities and the permissions required for the organisations and activities involved, separately from the study plan.
Comparator information
Identify the comparator, proposed source and documentary requirements, together with the permissions required for importation and study use regardless of authorisation elsewhere.
Blinding and packaging
Describe the sponsor’s requirements and study-specific blinding, packaging and accountability controls without disclosing unnecessary allocation information.
Trial labelling
Identify the countries, applicable study documentation and the party responsible for approving labels, using study-specific labels and instructions rather than website product records.
Distribution and accountability
An enquiry should distinguish shipment, storage, receipt, returns and reconciliation responsibilities.
Permissions and contact
Email [email protected]. Do not send participant records or confidential study documents in an initial message.
Prerequisites
The company holds no pharmaceutical manufacturing licence or GMP certificate. Any proposed activity requires evidenced capability, applicable authorisations and a separate agreement. Applicable authorisations include the relevant medicines, trial, ethics, import/export and other permissions. Sponsor responsibilities are not transferred merely by making an enquiry. Manufacture or supply of investigational medicines, a distribution network and clinical-supply capability require separate evidence.